Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between ITI FPO and Rossari Biotech IPO.
ITI FPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Rossari Biotech IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
| ITI FPO | Rossari Biotech IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | Mainline | Mainline |
| Issue Type | FPO | IPO |
| Process Type | Book Built Issue | Book Built Issue |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | Bob Capital Markets Limited Karvy Investor Services Limited Pnb Investment Services Ltd |
Axis Bank Limited ICICI Securities Limited |
| Registrar | Kfin Technologies Limited | Link Intime India Private Ltd |
| Market Maker | ||
| DRHP | DRHP  |
DRHP |
| RHP | RHP |
RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
The total issue size of ITI FPO is up to ₹1,399.86 Cr whereas the issue size of the Rossari Biotech IPO is up to ₹496.49 Cr. The final issue price of ITI FPO is and of Rossari Biotech IPO is ₹425.00 per share.
| ITI FPO | Rossari Biotech IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹2 per share |
| Issue Price (Lower) | ₹71.00 per share | ₹423.00 per share |
| Issue Price (Upper) | ₹77.00 per share | ₹425.00 per share |
| Issue Price (Final) | ₹425.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 150 shares | 35 shares |
| Fresh Issue Size | 18,00,00,000 shares | |
| Fresh Issue Size (Amount) | up to ₹50.00 Cr | |
| OFS Issue Size | 1,05,00,000 shares | |
| OFS Issue Size (Amount) | ||
| Issue Size Total | 18,18,00,000 shares | 1,16,82,033 shares |
| Issue Size Total (Amount) | up to ₹1,399.86 Cr | up to ₹496.49 Cr |
ITI FPO opens on Jan 24, 2020, while Rossari Biotech IPO opens on Jul 13, 2020. The closing date of ITI FPO and Rossari Biotech IPO is Feb 05, 2020, and Jul 15, 2020, respectively.
| ITI FPO | Rossari Biotech IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jan 24, 2020 | Jul 13, 2020 |
| Issue Close | Feb 05, 2020 | Jul 15, 2020 |
| Basis Of Allotment (Tentative) | Jan 31, 2020 | Jul 20, 2020 |
| Initiation of Refunds (Tentative) | Feb 03, 2020 | Jul 21, 2020 |
| Credit of Share (Tentative) | Feb 04, 2020 | Jul 22, 2020 |
| Listing date (Tentative) | Feb 05, 2020 | Jul 23, 2020 |
| Anchor Lockin End date 1 | Mar 01, 2020 | Aug 19, 2020 |
| Anchor Lockin End date 2 | Apr 30, 2020 | Oct 18, 2020 |
ITI FPO P/E ratio is , as compared to Rossari Biotech IPO P/E ratio of 33.81.
| ITI FPO | Rossari Biotech IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 89.97% | 95.06% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 74.83% | 73% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 33.81 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹8307.00 Cr. | ₹2207.00 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the ITI FPO retail investors (RII) are offered 1,80,00,000 shares while in Rossari Biotech IPO retail investors are offered 1,80,00,000 shares. Qualified institutional buyers (QIB) are offered 13,50,00,000 shares in ITI FPO and 23,35,294 shares in Rossari Biotech IPO.
| ITI FPO | Rossari Biotech IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | 13,50,00,000 shares | 23,35,294 shares |
| NII | 2,70,00,000 shares | 17,51,471 shares |
| RII | 1,80,00,000 shares | 40,86,765 shares |
| Employee | 18,00,000 shares | 0 shares |
| Others | ||
| Total | 18,18,00,000 shares | 81,73,530 shares |
ITI FPO subscribed 0.62x in total, whereas Rossari Biotech IPO subscribed 79.37x.
| ITI FPO | Rossari Biotech IPO | |
|---|---|---|
| QIB (times) | 0.63x | 85.26x |
| NII (times) | 0.23x | 239.83x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.06x | 7.23x |
| Employee (times) | 0.98x | |
| Other (times) | ||
| Total (times) | 0.62x | 79.37x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
